Skip to main content
. 2017 Dec 14;2(12):8969–8981. doi: 10.1021/acsomega.7b01454

Figure 4.

Figure 4

Comparison of the dissolution profiles in FaSSGF of the CFZ salts with CFZ F I and the commercial formulation of the drug (Lamprene).